These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18042179)

  • 21. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.
    Fumagalli F; Gainetdinov RR; Valenzano KJ; Caron MG
    J Neurosci; 1998 Jul; 18(13):4861-9. PubMed ID: 9634552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
    Quinton MS; Yamamoto BK
    Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.
    Hirata H; Ladenheim B; Carlson E; Epstein C; Cadet JL
    Brain Res; 1996 Apr; 714(1-2):95-103. PubMed ID: 8861613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.
    Hughes ZA; Stanford SC
    Psychopharmacology (Berl); 1998 Apr; 136(3):299-303. PubMed ID: 9566816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats.
    Fornai F; Torracca MT; Bassi L; D'Errigo DA; Scalori V; Corsini GU
    Brain Res; 1996 Oct; 735(2):349-53. PubMed ID: 8911678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social interactions in rats: behavioral and neurochemical alterations in DSP-4-treated rats.
    Zagrodzka J; Wieczorek M; Romaniuk A
    Pharmacol Biochem Behav; 1994 Nov; 49(3):541-8. PubMed ID: 7862705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
    Guillot TS; Shepherd KR; Richardson JR; Wang MZ; Li Y; Emson PC; Miller GW
    J Neurochem; 2008 Sep; 106(5):2205-17. PubMed ID: 18643795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxic effects of DSP-4 on the noradrenergic system of the goldfish brain.
    Villani L; Guarnieri T; Facchinetti F; Virgili M; Poli A
    Brain Behav Evol; 1996; 47(5):219-24. PubMed ID: 8724644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.
    Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC
    Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.
    Miyazaki I; Asanuma M; Diaz-Corrales FJ; Fukuda M; Kitaichi K; Miyoshi K; Ogawa N
    FASEB J; 2006 Mar; 20(3):571-3. PubMed ID: 16403784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.